This Article  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (1)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

UDO J. WILE, M.D.

AMA Arch Derm. 1956;73(5):480-481.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

There is perhaps no story in medical history attended by more dramatic events than the discovery of the infectious agent of syphilis in 1905, followed soon after by the demonstration by Wassermann of specific blood changes in the disease.

The awakened interest in the etiology and specific blood changes led to newer and more effective forms of treatment which began with the introduction by Ehrlich of intramuscular, later intravenous, Salvarsan in the treatment program. These two discoveries initiated a tremendous world-wide interest among scientists and clinicians.

The public health aspect of syphilis became more and more a matter of general interest. The final achievement of syphilis control came with the substitution of all previous methods of treatment, by the use of Alexander Fleming's penicillin in the treatment program. What for hundreds of years had failed to achieve more than amelioration, could now be completely eradicated in . . . [Full Text PDF of this Article]

Author Affiliations
Ann Arbor, Mich.

Professor Emeritus of Dermatology and Syphilology, University of Michigan Medical School.

Footnotes
Submitted for publication Jan. 21, 1956.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?